青光眼市场, [By Product (Alpha Agonist, Beta Blockers, Cholinergic, Carbonic Anhydrase Inhibitors, Prostaglandin Analogues (PGAs)), By Surgery (Conventional Glaucoma Surgeries, and Minimal Invasive Glaucoma Surgeries); By Indication (Secondary Glaucoma, Angle Closure Glaucoma (ACG), Open Angle Glaucoma (OAG), Congenital Glaucoma, and Other Indications); By End Use (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacy Stores)]; and Geography - Trend, Analysis and Forecast till 2025

发布日期：2018年8月
页数：0
格式：PDF.
报告ID：PM1366
基准年：
历史数据：

报告摘要

全球青光眼市场is driven by the factors such as increasing geriatric population and increasing demand for the combination drugs by end users.

青光眼是盲目的第二个最常见的主要原因，并且在老年人口中通常观察到。这种疾病损害了视神经，由于额外的液体造成的额外的液体，导致眼睛的压力增加。青光眼通常以隧道视觉，眼睛疼痛，模糊的视觉和红眼等症状为特征。

存在于前房中和出在眼睛附近的组织中的透明液体。通常，有两种类型的青光眼即可;主要开放角青光眼和角度闭合青光眼。初级开口角胶质瘤是最常见的青光眼类型，其在虹膜中发现非常靠近眼睛中的排水角度。青光眼的治疗主要集中在眼中的改善或减少其生产。主要用过的眼药水包括前列腺素类似物，胆碱能药物和β受体阻滞剂。尽管如此，高采用率，眼滴具有相对副作用，导致肾脏石，减肥，阳痿和疲劳等慢性疾病。

增加老年人的人口和青光眼的早期诊断协助全球青光眼市场的增长

The growth in this market is primarily driven by the increasing number of fixed-dose combination that are used for treating glaucoma and increasing geriatric population. Additionally, increasing awareness for diagnosis of glaucoma at the initial stage is also resulting in growth of this entire industry. Also, development of new phase drugs by the biopharmaceutical companies and government initiatives for supporting the drug development is expected to increase the market for glaucoma during the forecast period. Moreover, rapid technological advancements in the devices that are used in surgeries would also stimulate the growth of this market.

However, lack of awareness about glaucoma treatment by using various surgical devices across developing countries would impede the growth of global glaucoma market in the near future.

全球青光眼市场分类

全球青光眼市场is segmented on the basis of product, surgery, indication, and by end use and geography.

On the basis of product type, market is segmented as

α激动剂
Beta Blockers
Cholinergic
碳酸酐酶抑制剂
Prostaglandin Analogues (PGAs)

On the basis of surgery type, market is segmented as

Conventional Glaucoma Surgery
最小的侵袭性青光眼手术

在指示类型的基础上，市场被分段为

二级青光眼
角度闭合青光眼（ACG）
Open Angle Glaucoma (OAG)
其他

在最终使用类型的基础上，市场被分段为

医院药店
零售药房
在线药房商店

地理上，全球青光眼市场分为北美，欧洲，亚太地区，拉丁美洲和中东和非洲。技术进步与创新疫苗和有利的政府政策，以引领北美青光眼市场的增长。

在地理的基础上，预计北美地区将在预测期间主导全球青光眼市场。影响该地区青光眼市场生长的主要因素是遵守增长的老年人口的青光眼的升高。此外，预计政府对青光眼的关键制造商和重型研究和发展投资的可用性将对北美青光眼市场的增长产生积极影响。另一方面，增加对这些药物的意识也促进了不久的将来的市场增长。虽然，欧洲地区被观察到在这个市场上持有第二大市场份额。

然而，观察到亚太地区在预测期间以更快的速度增长。越来越令人意识到使用新药物的使用，通过关键付款人提高经济环境，以重点关注未开发的市场，而越来越多的政府对促进最小侵入性的手术的关注是在即将到来的几年期间亚太地区的青光眼市场增长的主要因素。